Vascular Ehlers-Danlos Syndrome Mutations in Type III Collagen Differently Stall the Triple Helical Folding
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Vascular Ehlers-Danlos syndrome (EDS) type IV is the most severe form of EDS. In many cases the disease is caused by a point mutation of Gly in type III collagen. A slower folding of the collagen helix is a potential cause for over-modifications. However, little is known about the rate of folding of type III collagen in patients with EDS. To understand the molecular mechanism of the effect of mutations, a system was developed for bacterial production of homotrimeric model polypeptides. The C-terminal quarter, 252 residues, of the natural human type III collagen was attached to (GPP) 7 with the type XIX collagen trimerization domain (NC2). The natural collagen domain forms a triple helical structure without 4-hydroxylation of proline at a low temperature. At 33 °C, the natural collagenous part is denatured, but the C-terminal (GPP) 7 -NC2 remains intact. Switching to a low temperature triggers the folding of the type III collagen domain in a zipper-like fashion that resembles the natural process. We used this system for the two known EDS mutations (Gly-to-Val) in the middle at Gly-910 and at the C terminus at Gly-1018. In addition, wild-type and Gly-to-Ala mutants were made. The mutations significantly slow down the overall rate of triple helix formation. The effect of the Gly-to-Val mutation is much more severe compared with Gly-to-Ala. This is the first report on the folding of collagen with EDS mutations, which demonstrates local delays in the triple helix propagation around the mutated residue. Background: Mutations in collagen may lead to posttranslational over-modifications and a delay in secretion. Results: Mutations locally delay the propagation of the triple helix. Conclusion: Position and nature of a mutation are the key factors in the triple helix folding delay. Significance: Consequences of natural collagen mutations can be now analyzed in terms of rate of folding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liu, X., Wu, H., Byrne, M., Krane, S., & Jaenisch, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1852 · Cited by 614
Crystal structure of an isoleucine-zipper trimer
Harbury, P. B., Kim, P. S., & Alber, T. (1994) · Nature · doi:10.1038/371080a0 · Cited by 472 · cited 1×
“3 nm as determined by the crystal structure of the trimeric coiled coil leucine zipper GCN4 from yeast (36).”
BackgroundA Heritable Disorder of Connective Tissue: Hydroxylysine-Deficient Collagen Disease
Pinnell, S. R., Krane, S. M., Kenzora, J. E., & Glimcher, M. J. (1972) · New England Journal of Medicine · doi:10.1056/nejm197205112861901 · Cited by 414 · cited 1×
“Genetic studies have shown that the genes of types I, III, and V collagens (2), lysylhydroxylase 1 (coded by PLOD1 gene) (3), procollagen-N-proteinase (coded by ADAMTS2 gene) (4), FKBP22 (coded by FKBP14 gene) (5), and tenascin X (coded by TNXB gene) (6) cause EDS.”
BackgroundThe Ehlers–Danlos syndrome, a disorder with many faces
De Paepe, A., & Malfait, F. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01858.x · Cited by 379 · cited 1×
“Ehlers-Danlos syndrome (EDS)(2) comprises a wide variety of soft connective tissue disorders (1).”
BackgroundTenascin-X deficiency is associated with Ehlers-Danlos syndrome
Burch, G. H., Gong, Y., Liu, W., Dettman, R. W., Curry, C. J., Smith, L., Miller, W. L., & Bristow, J. (1997) · Nature Genetics · doi:10.1038/ng0997-104 · Cited by 366 · cited 1×
“Genetic studies have shown that the genes of types I, III, and V collagens (2), lysylhydroxylase 1 (coded by PLOD1 gene) (3), procollagen-N-proteinase (coded by ADAMTS2 gene) (4), FKBP22 (coded by FKBP14 gene) (5), and tenascin X (coded by TNXB gene) (6) cause EDS.”
BackgroundSchwarze, U., Schievink, W. I., Petty, E., Jaff, M. R., Babovic-Vuksanovic, D., Cherry, K. J., Pepin, M., & Byers, P. H. (2001) · The American Journal of Human Genetics · doi:10.1086/324123 · Cited by 184
Baumann, M., Giunta, C., Krabichler, B., Rüschendorf, F., Zoppi, N., Colombi, M., Bittner, R. E., Quijano-Roy, S., Muntoni, F., Cirak, S., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.12.004 · Cited by 162
Colige, A., Nuytinck, L., Hausser, I., van Essen, A. J., Thiry, M., Herens, C., Adès, L. C., Malfait, F., Paepe, A. D., Franck, P., et al. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23406.x · Cited by 139
Smith, L. T., Schwarze, U., Goldstein, J., & Byers, P. H. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12286441 · Cited by 99
Smith, L. B., Hadoke, P. W. F., Dyer, E., Denvir, M. A., Brownstein, D., Miller, E., Nelson, N., Wells, S., Cheeseman, M., & Greenfield, A. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq356 · Cited by 81 · cited 1×
“In addition, haploinsufficiency of type III collagen in humans (18) and mice (19, 20) also leads to EDS, suggesting that the amount of type III collagen is also important.”
Background
Cited by
The Collagen Suprafamily: From Biosynthesis to Advanced Biomaterial Development
Sorushanova, A., Delgado, L. M., Wu, Z., Shologu, N., Kshirsagar, A., Raghunath, R., Mullen, A. M., Bayon, Y., Pandit, A., Raghunath, M., et al. (2019) · Advanced Materials · doi:10.1002/adma.201801651 · Cited by 1,151
Frank, M., Albuisson, J., Ranque, B., Golmard, L., Mazzella, J.-M., Bal-Theoleyre, L., Fauret, A.-L., Mirault, T., Denarié, N., Mousseaux, E., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.32 · Cited by 248
Extracellular matrix dynamics in vascular remodeling
Ma, Z., Mao, C., Jia, Y., Fu, Y., & Kong, W. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00147.2020 · Cited by 129
D'hondt, S., Guillemyn, B., Syx, D., Symoens, S., De Rycke, R., Vanhoutte, L., Toussaint, W., Lambrecht, B. N., De Paepe, A., Keene, D. R., et al. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.008 · Cited by 79
Self-citationIshikawa, Y., & Bächinger, H. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.561944 · Cited by 52
“Preparations of carboxyl-terminal quarter fragments of type III collagen with and without prolyl 4-hydroxylation were prepared as described previously (54, 55) Type I and Type III Collagen Fibril Formation Assay—Stock solutions of type I and type III collagen in 50 mM acetic acid were diluted in 0.”
MethodSelf-citation
Metadata
- Authors
- Mizuno, K., Boudko, S., Engel, J., & Bächinger, H. P.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 288
- Issue
- 26
- Pages
- 19166-19176
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1979247630
- Cited by
- 35
- References
- 11
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vascular Ehlers-Danlos Syndrome Mutations in Type III Collagen Differently Stall the Triple Helical Folding. https://app.cochat.ai/papers/10.1074/jbc.m113.462002
- The paper
- Mizuno, K., Boudko, S., Engel, J., & Bächinger, H. P. (2013). Vascular Ehlers-Danlos Syndrome Mutations in Type III Collagen Differently Stall the Triple Helical Folding. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m113.462002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.